dsRNA纳米融合制剂研制及对烟草普通花叶病毒和烟草脉带花叶病毒的抑制效果

    Study on nanoparticle-dsRNA formulations and inhibitory effects of TMV and TVBMV

    • 摘要: 由烟草普通花叶病毒 (TMV) 和烟草脉带花叶病毒 (TVBMV) 所致花叶病是烟草上的主要病害,严重威胁烟叶产业的可持续发展。纳米材料介导的RNA干扰 (RNAi) 是一种新型的绿色、安全、高效防治技术,在植物病毒病防治中有着巨大的应用潜力。本研究旨在筛选出对TMV和TVBMV病毒抑制效果最佳的靶标序列,并通过双链RNA (dsRNA) 纳米材料递送体系解析其对TMV和TVBMV的抑制效果。基于TMV基因组的外壳蛋白(CP) 和P126基因,以及TVBMV基因组的CP和HC Pro基因设计靶标片段,结合病毒诱导基因沉默 (VIGS) 试验,明确不同片段对TMV和TVBMV的抑制效果,筛选最佳靶标片段。体外合成dsRNA,并分别与3种纳米材料壳聚糖 (CS)、碳量子点 (CQD) 和石墨烯量子点 (GQD) 融合,筛选最佳融合比例并制备得到纳米材料-dsRNA制剂,通过激光粒度仪、Zeta电位测试仪和透射电镜对3种纳米制剂进行了表征,验证了3种制剂对TMV和TVBMV的抑制效果。结果表明:VIGS注射P126对TMV的抑制效果较好,平均抑制率为53.96%;VIGS注射V-HC对TVBMV的抑制效果较好,平均抑制率为61.22%;表明P126和HC Pro基因片段为TMV和TVBMV的最佳靶标。dsRNA和纳米材料的融合试验表明,dsRNA和CS的最佳融合质量比为1∶1,dsRNA和CQD的最佳融合质量比为1∶10;dsRNA和GQD的最佳融合质量比为1∶7。纳米制剂的表征结果证明,dsRNA被成功负载在纳米材料上。纳米材料-dsRNA制剂对TMV和TVBMV的病毒抑制验证试验表明,纳米制剂显著提高了dsRNA对TMV和TVBMV的抑制效果,且GQD-dsRNA和CQD-dsRNA组合的抑制效果最佳。

       

      Abstract: The sustainable development of the tobacco industry was seriously threated by tobacco viral diseases, especially for Tobacco mosaic virus (TMV) and Tobacco vein banding mosaic virus (TVBMV). Nanomaterials for nucleic acid delivery system is a green, safe, and efficient approach with great potential for the prevention and control of plant viral diseases. In this study, the optimal target sequences were screened to analyze viral inhibition of TMV and TVBMV through fusion experiment of different nanomaterials. Coat protein (CP) and P126 fragments of TMV genome sequences, CP and HC Pro fragments of TVBMV genome sequences were synthesized to dsRNA in vitro. The viral inhibition of dsRNA on TMV and TVBMV were identidied by VIGS (virus induced gene silencing) experiments. Fusion experiments between dsRNA and three types of nanomaterials, chitosan (CS), carbon quantum dots (CQD), and graphene quantum dots (GQD) were conducted to identify optimal fusion ratio. Three nanoparticle-dsRNA complexes were characterized by particle size testing instrument, Zeta potential testing instrument, and transmission electron microscope (TEM). The viral inhibition effect of three nanoparticle-dsRNA complexes were also tested. The results showed that P126 fragment of TMV and V-HC fragment of TVBMV obtained the better results by VIGS injection (average incidence inhibition rate of 53.96% and 61.22%, respectively). The results of dsRNA injection were consistent with those of VIGS injection. The dsRNA of P126 fragment had a better viral inhibition on TMV (with an average incidence inhibition rate of 58.67%), dsRNA of V-HC fragment had a better viral inhibition on TVBMV (with an average inhibition rate of 48.11%). Thus, P126 fragment and HC Pro fragment are the best targets for viral inhibition of TMV and TVBMV. The fusion experiment between dsRNA and nanomaterials indicated that the optimal fusion mass ratio of dsRNA to CS was 1∶1, and the optimal mass fusion ratio of dsRNA to CQD was 1∶10, the optimal fusion mass ratio of dsRNA and GQD was 1∶7. Nanoparticle-dsRNA complexes were characterized by particle size analysis, Zeta potential, transmission electron microscope, which proved that nanoparticle and dsRNA were successfully self-assembled. The viral inhibition experiment on TMV and TVBMV proved that nanoagents obtained significantly better viral inhibitory effect, and that CQD-dsRNA and GQD-dsRNA were the optimal nanoparticle-dsRNA complexes.

       

    /

    返回文章
    返回